the volume and pps will be much higher Q3 and into 2018 and beyond when revenues are coming in and the myeloma treatment progresses...and other things for that matter....
patience is a virtue but very lacking today...
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links